Five reasons that many comparative effectiveness studies fail to change patient care and clinical practice

Health Affairs

Volumn 31, Issue 10, 2012, Pages 2168-2175

  Timbie, Justin W ^a   Fox, D Steven ^a   Van Busum, Kristin ^a   Schneider, Eric C ^a  

^a RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NEUROLEPTIC AGENT; THIAZIDE DIURETIC AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COMPARATIVE EFFECTIVENESS; CONSENSUS; DECISION MAKING; HUMAN; MEDICAL PRACTICE; PATIENT CARE; PHYSICIAN; ROOT CAUSE ANALYSIS; SCHIZOPHRENIA;

COMPARATIVE EFFECTIVENESS RESEARCH; DIFFUSION OF INNOVATION; HUMANS; PATIENT CARE; PHYSICIAN'S PRACTICE PATTERNS; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES;

EID: 84871956674     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2012.0150     Document Type: Article

References (31)

1. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004;291(1):47-53.
2. Stadtmauer EA, O'Neill A, Goldstein LJ, Crilley PA, Mangan KF, Ingle JN, et al. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. N Engl J Med. 2000;342(15):1069-76.
3. Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, et al. Overdiagnosis due to prostatespecific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst. 2002; 94(13):981-90.
4. Pollack A. The minimal impact of a big hypertension study. New York Times. 2008 Nov 28.
5. To access the Appendix, click on the Appendix link in the box to the right of the article online
6. Schneider EC, Timbie JW, Fox DS, Van Busum K, Caloyeras JC. Dissemination and adoption of comparative effectiveness research findings when findings challenge current practices. Santa Monica (CA): RAND Corporation; 2011.
7. Robinson JC. Comparative effectiveness research: from clinical information to economic incentives. Health Aff (Millwood). 2010;29(10): 1788-95.
8. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356(15):1503-16.
9. Weinstein JN, Tosteson TD, Lurie JD, Tosteson ANA, Blood E, Hanscom B, et al. Surgical versus nonsurgical therapy for lumbar spinal stenosis. N Engl J Med. 2008; 358(8):794-810.
10. Avorn J. Transforming trial results into practice change: the final translational hurdle: Comment on "Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic use." Arch Intern Med. 2010;170(10):858-60.
11. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209-23.
12. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-97.
13. Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC Jr. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA. 2009;301(8):831-41.
14. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140-50.
15. Friedewald VE Jr., Boehmer JP, Kowal RC, Saxon L, Yancy CW, RobertsWC. The editor's roundtable: cardiac resynchronization therapy. Am J Cardiol. 2007;100(7):1145-52.
16. Murphy ML, Hultgren HN, Detre K, Thomsen J, Takaro T. Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration cooperative study. N Engl J Med. 1977;297(12):621-7.
17. Pines JM. Profiles in patient safety: confirmation bias in emergency medicine. Acad Emerg Med. 2006; 13(1):90-4.
18. Kaptchuk TJ. Effect of interpretive bias on research evidence. BMJ. 2003;326(7404):1453-5.
19. Carpenter WT, Buchanan RW. Lessons to take home from CATIE. Psychiatr Serv. 2008;59(5):523-5.
20. Ayanian JZ, Berwick DM. Do physicians have a bias toward action? A classic study revisited. Med Decis Making. 1991;11(3):154-8.
21. Topol EJ, Nissen SE. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation. 1995;92(8):2333-42.
22. Owen R. Reader bias. JAMA. 1982;247(18):2533-4.
23. Emanuel EJ. What cannot be said on television about health care. JAMA. 2007;297(19):2131-3.
24. Bates DW, Pappius E, Kuperman GJ, Sittig D, Burstin H, Fairchild D, et al. Using information systems to measure and improve quality. Int J Med Inform. 1999;53(2-3):115-24.
25. Hunt DL, Haynes RB, Hanna SE, Smith K. Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA. 1998;280(15):1339-46.
26. CMS.gov. EHR Incentive Programs [Internet]. Baltimore (MD): Centers for Medicare and Medicaid Services; [last modified 2012 Aug 27; cited 2012 Sep 6]. Available from: http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/index.html?redirect=/ehrincentiveprograms/
27. Institute of Medicine. Clinical practice guidelines we can trust. Washington (DC): National Academies Press; 2011. p. 93.
28. American Medical Association. Physician Consortium for Performance Improvement [Internet]. Chicago (IL): AMA; [cited 2012 Sep 6]. Available from: http://www.ama-assn.org/ama/pub/physician-resources/physicianconsortium-performanceimprovement.page
29. Ginsburg M. Value-based insurance design: consumers' views on paying more for high-cost, low-value care. Health Aff (Millwood). 2010;29(11): 2022-6.
30. Robinson JC. Applying value-based insurance design to high-cost health services. Health Aff (Millwood). 2010;29(11):2009-16.
31. Fendrick AM, Smith DG, Chernew ME. Applying value-based insurance design to low-value health services. Health Aff (Millwood). 2010;29(11): 2017-21.